0% 01mar2026 0% 01mar2026 (FR0013238417)

Its just market makers or some BS. This thing is trash its always been trash and any of us that got suckered into investing deserve this. There's nothing here its a shell game and we're all bag holding idiots.

I guess this will never move!! Good job Logan. 

CRNX another good example of a buyout before phase 3 results of their lead candidate.

Sorry, deniers need facts not just their rabid opinions.

naked short selling must stop. file compliant with sec . i have had no luck with sec filing complaints ever but may be you will. this is real, naked short selling going on and large banks making a ton and manipulating. not uplisting is like promoting such fraud. no reason not to, a low hanging fruit

Executing the Strategy🤑

Execution remained the defining theme throughout the second quarter as Suntex continued strengthening its diversified operating platform across its seven wholly owned subsidiaries serving construction, electrical contracting, infrastructure, land develo

Sorry, deniers need facts not just their rabid opinions.

We're talking about OTC. NASDAQ already pushed NWBO out.

One of these days you will be right.

Clearly no "valid clinical design" as FDA wasn't buying it. Just watch, NWBO won't apply for U.S. approval until they do another trial. P3 trial was manipulated.

I remember about 10 years ago there was a job posting for a job relating to stock market compliance, don't remember the title exactly, and we all got excited. Well, 10 years has passed.

Get money my g Im pulling for you, I hope this gem of gems come through for you.

Mitsubishi UFJ Financial Group, Inc. Announces Filing of Annual Report on Form 20-F for the Year Ended March 31, 2026July 6, 2026 9:57 PM
Business WireMitsubishi UFJ Financial Group, Inc. (NYSE:MUFG)(TOKYO:8306)(ISIN:JP3902900004)(MUFG) hereby announces that it

#1.2 SPX Cycles Expanded Report: Current Cycles Between Cycles (CCBC) is -37 (Extreme Bearish). Extreme Overdue: 60 min (60-E-1,60-2), Daily (D-2), Weekly (W-SC-1).

https://investorshub.advfn.com/uimage/uploads/2026/7/6/ipnir1_Status_Report.PNG

#1.2 SPX Cycles Expanded Report: Current Cycles Between Cycles (CCBC) is -37 (Extreme Bearish). Extreme Overdue: 60 min (60-E-1,60-2), Daily (D-2), Weekly (W-SC-1).

https://investorshub.advfn.com/uimage/uploads/2026/7/6/ipnir1_Status_Report.PNG

It is a good position to be in from a cost standpoint. The key to maximizing our gross margin is to articulate our value proposition on a total cost of ownership basis vs our incumbent competition. We don’t need to dramatically undercut the competition. If our power savings saves the customer $10, t

Lawyers for large companies happen all the time regular sop

Meanwhile I really like the future of this company.

JHD

Percentage of Shares Shorted
2.73% of the float of CytoDyn has been sold short.
Short Interest Ratio / Days to Cover
CytoDyn has a short interest ratio ("days to cover") of 12.25

Everyone save back a little extra cash and pile on for the moment the news hits that

LP’s dream

Be sure to mention to Moss if you’re a shareholder.

82 cents to 36 cents.

Probably because 95% of all press releases are BS. Fahman has never produced anything other than shares to sell.